
No transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2018-03-20 | Greg Gianforte | house | Purchase | $100,001 - $250,000 |
No financial data available for NVZMY.
Company may not file with SEC or CIK is unresolved.
FUL vs. NVZMY: Which Stock Should Value Investors Buy Now?
Novozymes Dividend Increase And Valuation Discount Catch Investor Attention
FUL or NVZMY: Which Is the Better Value Stock Right Now?
Novozymes A/S (NVZMY) Shareholder/Analyst Call - Slideshow
Novozymes A/S (NVZMY) Shareholder/Analyst Call Transcript
Resolutions from the Annual General Meeting 2026
Novonesis issues EUR 1.7 billion in bonds to refinance bridge facility
Top and bottom quant-rated materials stocks over $10B: Coeur Mining leads 'Strong Buys'
Novonesis issues EUR 1.7 billion senior unsecured notes
Novozymes Balances Tighter Meeting Access With Higher Dividend Payout Ratio
Novonesis named a Great Employer to Work For in North Carolina
Novozymes A/S Non-GAAP EPS of €1.49, revenue of €4.16B